CARYN SCOTT: Open Payments
NPI 1023091618 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 13 companies in 2025. Trend: 2023 $124 · 2024 $233 · 2025 $395
Food & beverage: $379Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Amgen Inc. | 2 | $41 |
| PFIZER INC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $40 |
| ABBVIE INC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: SHINGRIX, AIRSUPRA, VRAYLAR, OTEZLA, GEMTESA, Auvelity, PAXLOVID, JARDIANCE.
Industry payments across OR — which companies pay providers there.
